Biomarkers for pancreatic cancer: is it ready for primetime?

JOP. 2013 Jul 10;14(4):309-11. doi: 10.6092/1590-8577/1676.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / metabolism*
  • Dihydrouracil Dehydrogenase (NADP) / metabolism
  • Equilibrative Nucleoside Transporter 1 / metabolism
  • Humans
  • Osteonectin / metabolism
  • Outcome Assessment, Health Care
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / metabolism*
  • Prognosis

Substances

  • Biomarkers, Tumor
  • Equilibrative Nucleoside Transporter 1
  • Osteonectin
  • SLC29A1 protein, human
  • SPARC protein, human
  • Dihydrouracil Dehydrogenase (NADP)